CFTR modulator therapy Elexacaftor/Tezacaftor/Ivacaftor (ETI) is effective in people with CF (pwCF) with rare non-phe508del CFTR mutations that permit the production of some CFTR protein. The gene discussed is CFTR; the disease is cystic fibrosis.